CADL
Candel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.78
−1.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 84.70x
- P/S forward
- 56.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.75x
- Price / sales
- —
- Price / cash flow
- -17.46x
Enterprise value
- Enterprise value
- $825.9M
- EV / sales
- —
- EV / EBITDA
- -9.95x
- EV / EBIT
- -11.47x
- Market cap
- $977.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026